Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man.
The etiology of tumor-induced hypercalcemia was investigated in a transplantable Leydig cell tumor of the Fischer rat. In this model, serum calcium rose from a baseline of 10.4 +/0 0.3 mg/dl to 12.5 + 0.4 mg/dl at day 10 and 16.4 +/- 1.3 mg/dl (p less than 0.001) at day 13 post transplant. Urinary calcium also increased from 1.52 +/- 0.17 mg/d to 3.52 + 0.72 mg/d (Day 12, p less than 0.01). Serum phosphate decreased from a baseline of 7.5 +/- 0.3 mg/dl to 5.5 +/- 0.6 mg/dl at day 13 (p less than 0.05). At day 13 serum immunoreactive parathyroid hormone levels fell 76% from baseline (p less than 0.01). Calcitonin increased from 59 +/- 2 pg/ml to 88 +/- 9 pg/ml (p less than 0.02). The plasma prostaglandin E metabolite, 13,14-dihydro-15-keto-PGE2 increased from 407 +/- 103 pg/ml to 647 +/-62 pg/ml (p less than 0.05) and the active Vit D compound 1,25(OH)2D increased from 94.8 +/- 5.2 pg/ml to 162.3 +/- 11.8 pg/ml (p less than 0.01). Urinary cyclic AMP did not decrease in parallel with the parathyroid hormone level and, in fact, increased from 146 +/- 3 nmol/d to 172 +/- 27 nmol/d (NS). Administration of the cyclooxygenase inhibitor indomethacin (20 mg/Kg/d) or hydrocortisone (50 mg/Kg/d) did not prevent the development of hypercalcemia. This model is similar to many patients with humoral hypercalcemia of malignancy who demonstrate suppression of parathyroid hormone with elevated urinary cyclic AMP excretion and may prove useful in the understanding of the responsible mechanisms.
D000818:Animals; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000652:urine; D000242:Cyclic AMP / Q000652:urine; D015232:Dinoprostone / Q000031:analogs & derivatives*; D004195:Disease Models, Animal; D006934:Hypercalcemia / Q000150:complications*; D007984:Leydig Cell Tumor / Q000150:complications*; D008297:Male; D009368:Neoplasm Transplantation; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000652:urine; D011458:Prostaglandins E / Q000097:blood; D051381:Rats; D011916:Rats, Inbred F344; D013736:Testicular Neoplasms / Q000150:complications*
D010281:Parathyroid Hormone; D010710:Phosphates; D011458:Prostaglandins E; C025087:15-keto-13,14-dihydroprostaglandin E2; D000242:Cyclic AMP; D002117:Calcitriol; D015232:Dinoprostone; D002118:Calcium